Remaxol: Clinical Trials

5 trials of Remaxol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Remaxol: new trials by email Literature Review of Remaxol trials Research Report on Remaxol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
Remaxa, enteric-coated tablets, Remaxol, Placebo - Cholestasis, Intrahepatic
Phase 2 / Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company3282023-05-272025-04-29
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
Remaxol - Gallstone Disease, Obstructive Jaundice
CompletedPOLYSAN Scientific & Technological Pharmaceutical Company2862022-12-012026-04-21
Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
Remaxol - Cancer, Drug Induced Liver Injury
CompletedPOLYSAN Scientific & Technological Pharmaceutical Company3682022-05-122025-08-13
Remaxol® in Mechanical Jaundice of Non-malignant Origin
Remaxol (succinate + methionine + inosine + nicotinamide), Ringer's Solution - Jaundice, Obstructive
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company3422017-04-032020-07-14
Remaxol® in Malignant Mechanical Jaundice
Remaxol®, Ringer's Solution - Jaundice; Malignant
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company2402017-04-032020-07-10

Conditions studied

Jaundice, Obstructive (3)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Cholelithiasis (1)  ·  Cholestasis, Intrahepatic (1)  ·  Jaundice (1)  ·  Neoplasms (1)

Sponsors

POLYSAN Scientific & Technological Pharmaceutical Company (5)

Countries

Russia (5)

Top investigators

Mikhail S. Bogomolov, MD, PhD (2)  ·  Tatiana V Kharitonova, MD PhD (1)